공고 • Aug 12
Align Technology Prevails In China Patent Infringement Action Against Angelalign Align Technology Inc. announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China. In September 2025, Align filed a patent infringement action against Angel in the Jinan Intermediate People's Court, asserting Align’s patent related to extraction-gap-closure technology (CN113693748B). On August 10, 2026, the Jinan Intermediate People's Court issued a first-instance judgment finding that Angel's use of its MasterForce biomechanical simulation system and ATreat digital orthodontic treatment design system to generate A7 and A7 Speed premolar extraction treatment solutions infringes Align's patent rights. The court further found that the related aligner products manufactured and sold using the accused technology also infringe Align's patent. Angel may appeal the judgment to the Supreme People's Court. The deadline for filing an appeal has not yet expired. The court ordered Angel to cease using the patented technology and to stop manufacturing and selling the infringing products in China and awarded Align RMB 10 million in damages. The ruling remains subject to appeal. The ruling follows other recent developments in Align's patent-enforcement actions against Angel. In February 2026, the Unified Patent Court issued a preliminary injunction requiring Angel to cease infringement of Align's patented ClinCheck Live Update technology, a decision that was subsequently upheld on appeal. In July 2026, the U.S. International Trade Commission conducted an evidentiary hearing concerning five patents asserted by Align against Angel. Align expects that the ITC will make its initial determination regarding the merits of Align’s claims in November 2026. Align also continues to pursue additional patent infringement actions against Angel affiliates in China and Europe. 공고 • Jul 08
Angelalign Technology Inc. Launches Iortho Release 6.2 With New CBCT Visualization, Trimline Flexibility, And Redesigned Prescription Form Angelalign Technology Inc. launched iOrtho Release 6.2 with new improvements in CBCT visualization, new trimline flexibility and a redesigned Rx form. The release puts real clinical advances directly in doctors' hands, from fuller CBCT visualization featuring new 3D diagnostic views, to multiple trimline options, to a redesigned Rx for Primary and Refinement cases, alongside a set of optimizations that sharpen the tools doctors rely on day to day. Release 6.2 reflects Angel Aligner's continued investment in giving orthodontists the tools to treat with confidence. New improvements in CBCT Visualization: IRS (Intelligent Root System) Gold provides detailed 3D visualizations of cortical and cancellous bone, maxillary sinus, and airway structures for more comprehensive case evaluation. Updated color mapping also makes it easier to distinguish tissue types at-a-glance, helping doctors evaluate anatomical structures more efficiently during case review. Variable Trimline in Rx: For the first time, three trimline options — Standard (scalloped), Full-Arch High, and High at Posterior Teeth Only — are built directly into the Rx form, giving doctors more control at the prescription stage, before setup even starts. There's flexibility after the fact too: doctors can downgrade their trimline selection directly in iOrtho at approval, and upgrade from Posterior Only to Full-Arch on their own. Redesigned Prescription Form for Primary and Refinement Cases: For both Primary and Refinement cases, the prescription form is being redesigned for all users to give doctors more clinical control right at the point of prescription. Building on existing Rx capabilities, the updated form expands what doctors can specify at the prescription stage, giving them more clinical control before setup even begins. Refreshed Treatment Plan Interface: The 3D user interface has been redesigned to make planning faster and more intuitive. The 3D modification tools (Tooth, Features, Arch, Occlusal Plane) now sit in the top-right of the 3D view, so doctors can access and switch between them more easily. This helps doctors evaluate treatment options more efficiently and with greater confidence. Additional Improvements From Doctor Feedback: Beyond the major features, Release 6.2 includes several smaller improvements that came directly from doctor feedback. Each update addresses a specific request raised by orthodontists using the platform. iOrtho Release 6.2 went live July 1. 공고 • May 14
Angelalign Technology Inc. Applauds European Court Rejection of Patent Infringement Claim Angelalign Technology Inc. said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (ALGN) for Angel to cease and desist from using its A7 Premolar Extraction Solution. Angel denied that the A7 tooth movement protocol infringes any patents as alleged by Align Technology Inc. (ALGN). The court rejected Align’s request for Angel to preliminarily cease its use of the feature, a decision Angel applauded. 공고 • Mar 29
Angelalign Technology Inc. Proposes Special Dividend for the Financial Year End December 31, 2025, Payable on June 8, 2026 Angelalign Technology Inc. proposed special dividend of HKD 4.99 per share for the financial year end 31 December 2025. Date of shareholders' approval 19 May 2026, Ex-dividend date 21 May 2026, Record date 28 May 2026 and Payment date 08 June 2026. 
